Cleocin 100 MG Vaginal Suppository Duration
Prescribe Cleocin (clindamycin phosphate) 100 mg vaginal suppositories for 3 days in non-pregnant women or 7 days in pregnant women, administered intravaginally at bedtime. 1
Treatment Duration by Patient Population
Non-Pregnant Women
The FDA-approved dosing for clindamycin phosphate vaginal cream 2% (containing approximately 100 mg clindamycin phosphate per 5g applicator) is either 3 or 7 consecutive days 1. However, the 3-day regimen offers equivalent efficacy with improved tolerability:
- 3-day regimen: One applicatorful (100 mg) intravaginally at bedtime for 3 consecutive days
- 7-day regimen: One applicatorful (100 mg) intravaginally at bedtime for 7 consecutive days
The CDC guidelines consistently recommend clindamycin cream 2% for 7 days as a standard regimen for bacterial vaginosis 2, 3. However, the alternative regimen of clindamycin ovules 100 mg intravaginally once at bedtime for 3 days is also recognized 3.
Pregnant Women
For pregnant patients, prescribe the 7-day regimen exclusively 1. The FDA label specifically states that pregnant women should receive treatment for 7 consecutive days, not the shorter 3-day course.
Evidence Supporting Treatment Duration
The choice between 3-day and 7-day regimens is supported by clinical trial data:
- Efficacy equivalence: A randomized trial comparing 3-day clindamycin ovules versus 7-day clindamycin cream found cure rates of 53.7% versus 47.8% respectively (not statistically different, p=0.2471) 4
- Better tolerability: The 3-day regimen demonstrates fewer treatment-related adverse events compared to longer courses 5
- Patient preference: 86.5% of surveyed women preferred the 3-day ovule regimen, primarily citing the shorter treatment duration as increasing likelihood of completing therapy 6
Clinical Considerations
Important Caveats
- Oil-based formulation: Clindamycin cream contains mineral oil that may weaken latex condoms and diaphragms for up to 72 hours after treatment 1, 3
- Candida overgrowth: Vaginal candidiasis occurs in 7.7-13.3% of patients treated with clindamycin 1
- No partner treatment needed: Treating sexual partners does not affect cure rates or recurrence 3
Pregnancy-Specific Warnings
While clindamycin vaginal cream can be used in pregnancy, avoid topical clindamycin cream in pregnant women when possible due to evidence from three trials suggesting increased adverse events (prematurity, neonatal infections) after clindamycin cream use 3. If treating pregnant women, oral clindamycin 300 mg twice daily for 7 days is preferred over vaginal formulations 3.
When to Use Each Duration
- 3-day regimen: Appropriate for non-pregnant women seeking shorter treatment duration with equivalent efficacy
- 7-day regimen: Required for pregnant women; also appropriate for non-pregnant women, particularly those who prefer the traditional CDC-recommended duration
The FDA label provides flexibility for non-pregnant patients (3 or 7 days) while mandating 7 days for pregnant patients, reflecting both efficacy data and safety considerations 1.